BioAtla
BCAB
#11114
Rank
A$4.49 M
Marketcap
A$2.70
Share price
12.28%
Change (1 day)
182.59%
Change (1 year)

Earnings for BioAtla (BCAB)

Earnings in 2026 (TTM): -A$76.09 Million

According to BioAtla's latest financial reports the company's current earnings are A$2 Million. In 2025 the company made an earning of -A$83.72 Million, an increase over its 2024 earnings that were of -A$98.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioAtla from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$76.09 Million-9.12%
2025 -A$83.72 Million-14.57%
2024 -A$98.01 Million-43.48%
2023 -A$0.18 Billion15.95%
2022 -A$0.15 Billion11.61%
2021 -A$0.14 Billion166.09%
2020 -A$50.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 196.16%๐Ÿ‡บ๐Ÿ‡ธ USA